scholarly journals A CASE OF LUNG AND HILAR LYMPH NODE METASTASES DUE TO HEPATO-CELLULAR CARCINOMA WITH LONG-TERM SURVIVAL AFTER SURGICAL RESECTION

2009 ◽  
Vol 70 (4) ◽  
pp. 1029-1032 ◽  
Author(s):  
Masafumi KATAOKA ◽  
Takefumi NIGUMA ◽  
Tetsushige MIMURA ◽  
Kenta SUI ◽  
Ryuichi YOSHIDA ◽  
...  
Keyword(s):  
Lymph Node ◽  
Surgical Resection ◽  
Lymph Node Metastases ◽  
Term Survival ◽  
Hilar Lymph Node ◽  
Long Term Survival ◽  
Node Metastases ◽  
Cellular Carcinoma

scholarly journals The association between lymph node metastases and long-term survival in patients with epithelial ovarian cancer

2020 ◽  
Vol 24 (3) ◽  
pp. 163-171
Author(s):  
Katarzyna Lepinay ◽  
Sebastian Szubert ◽  
Agnieszka Lewandowska ◽  
Tomasz Rajs ◽  
Krzysztof Koper ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Lymph Node ◽  
Epithelial Ovarian Cancer ◽  
Lymph Node Metastases ◽  
Term Survival ◽  
Long Term Survival ◽  
Node Metastases

Long-term Survival After Gastric Cancer and Liver and Paraaortic Lymph Node Metastases: Report of a Case

Surgery Today ◽  
2001 ◽  
Vol 31 (2) ◽  
pp. 159-162 ◽  
Author(s):  
Yutaka Yoshizumi ◽  
Tomokazu Matuyama ◽  
Hiroshi Koike ◽  
Satoshi Aiko ◽  
Yoshiaki Sugiura ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Metastases ◽  
Paraaortic Lymph Node ◽  
Term Survival ◽  
Long Term Survival ◽  
Node Metastases

Typical Carcinoids of the Lung: Multicentric Forms, Lymph-node Metastases and Long-term Survival in 83 Patients

CHEST Journal ◽  
2004 ◽  
Vol 126 (4) ◽  
pp. 915S
Author(s):  
Piero Ferolla ◽  
Niccolo Daddi ◽  
Moira Urbani ◽  
Costanzo Fedeli ◽  
Mark Ragusa ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastases ◽  
Term Survival ◽  
Long Term Survival ◽  
Node Metastases

scholarly journals Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Shaocheng Lyu ◽  
Lixin Li ◽  
Xin Zhao ◽  
Zhangyong Ren ◽  
Di Cao ◽  
...  
Keyword(s):  
Risk Factors ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Lymph Node Dissection ◽  
Lymph Node Metastases ◽  
Term Survival ◽  
Distal Cholangiocarcinoma ◽  
Node Metastasis ◽  
Node Metastases

Abstract Background Pancreaticoduodenectomy is the only definitively curative therapy for the long-term survival of distal cholangiocarcinoma patients. Lymph node metastasis is widely accepted as an important prognostic factor for distal cholangiocarcinoma. The latest American Joint Committee on Cancer (AJCC) TNM classification system for distal cholangiocarcinoma has divided the lymph node metastasis patients into N1 and N2 by lymph node metastasis number. However, some studies suggested that the lymph node metastasis ratio may be better than the lymph node metastasis number. Therefore, we develop a program to analyze the correlation between lymph node parameters (lymph node dissection number, lymph node metastasis number, and lymph node metastasis rate) and long-term prognosis. Methods We retrospectively reviewed 123 distal cholangiocarcinoma patients after pancreatoduodenectomy from January 2011 to December 2019. The patients were grouped according to lymph node metastases and tumor-free and overall survival rates which were investigated with the Kaplan-Meier analysis. The logistic regression models were used for multivariate analysis to determine the risk factors for lymph node metastases. And the X-tile program was used to calculate the cutoff values for the lymph node parameters that discriminated survival. Results The 1-year, 3-year, and 5-year overall survival rates of patients with distal cholangiocarcinoma after pancreatoduodenectomy were 75.2%, 37.1%, and 31.5%, respectively. And the 1-year, 3-year, and 5-year overall survival rates of patients without and with lymph node metastasis were 83.0%, 50.7%, and 42.5% and 63.5%, 19.0%, and 19.0% (p = 0.000), respectively. Logistic regression showed CA19-9 and portal vein system invasion as independent risk factors for lymph node metastases. The receiver operating characteristic curve showed the optimal cutoff value of CA19-9 to predict the lymph node metastases was 75.5 U/mL. Determined by the X-tile software, the optimal cutoff values of the lymph node dissection number were 24 (p = 0.021), the lymph node metastasis number were 1 and 7 (p = 0.504), and the lymph node metastasis rate were 0.13 (p = 0.002). Conclusion Lymph node metastasis is an important factor affecting the long-term survival of distal cholangiocarcinoma patients.CA19-9 and portal vein system invasion are independent risk factors for lymph node metastasis. Besides, the lymph node dissection number and lymph node metastasis rate can predict the long-term survival better than lymph node metastasis number.

scholarly journals Long-Term Recurrence-Free Survival After Metachronous Surgery of the Stomach and Liver for Gastric Adenocarcinoma and Multiple, Synchronous Liver Metastases: A Case Report and Review of Literature

2013 ◽  
Vol 98 (3) ◽  
pp. 241-246 ◽  
Author(s):  
Yoshito Kiyasu
Keyword(s):  
Lymph Node ◽  
Liver Metastases ◽  
Gastric Adenocarcinoma ◽  
Lymph Node Metastases ◽  
Regional Lymph Node ◽  
Term Survival ◽  
Severe Diarrhea ◽  
Regional Lymph Node Dissection ◽  
Node Metastases

Abstract This report describes a 58-year-old woman with gastric adenocarcinoma and liver metastases, who survives for more than 18 years after diagnosis. At diagnosis and first surgery, a moderately differentiated gastric adenocarcinoma with subserosal invasion was detected, along with 2 regional lymph node metastases and 2 liver metastases. She underwent gastrectomy and regional lymph node dissection but did not undergo liver operation then. After gastrectomy, she received adjuvant chemotherapy for 1 month but discontinued it due to severe diarrhea. Another metastasis in another area of the liver was detected, for which she underwent excision of the right lobe of the liver (subsegments 5, 6, and 7) about 30 months later. No signs of recurrence have been detected for 18 years (as of March 2012). This patient represents a rare case of long-term survival of gastric adenocarcinoma without recurrence after surgical treatment, despite multiple, synchronous, liver and regional lymph node metastases.

Sign in / Sign up

Export Citation Format

Share Document